Integrated Safety and Efficacy Among Patients with Severe Asthma Receiving Benralizumab for Up to Five Years
Bourdin A, Korn S, Chupp G, Cosio B, Arbetter D, Shah M, Garcia Gil E. Integrated Safety and Efficacy Among Patients with Severe Asthma Receiving Benralizumab for Up to Five Years. 2021, a1205-a1205. DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1205.Peer-Reviewed Original Research